Literature DB >> 24793616

Invasive assessment of the coronary microcirculation using the index of microcirculatory resistance: description and validation of an animal model.

António Fiarresga1, Mafalda Selas2, Eunice Oliveira2, Sandra Cavaco-Gonçalves3, Duarte Cacela2, Belmira Carrapiço4, Nuno Cardim5, Rui Cruz Ferreira2.   

Abstract

INTRODUCTION: The index of microcirculatory resistance (IMR) enables/provides quantitative, invasive, and real-time assessment of coronary microcirculation status. AIMS: The primary aim of this study was to validate the assessment of IMR in a large animal model, and the secondary aim was to compare two doses of intracoronary papaverine, 5 and 10 mg, for induction of maximal hyperemia and its evolution over time.
METHODS: Measurements of IMR were performed in eight pigs. Mean distal pressure (Pd) and mean transit time (Tmn) were measured at rest and at maximal hyperemia induced with intracoronary papaverine, 5 and 10 mg, and after 2, 5, 8 and 10 minutes. Disruption of the microcirculation was achieved by selective injection of 40-μm microspheres via a microcatheter in the left anterior descending artery.
RESULTS: In each animal 14 IMR measurements were made. There were no differences between the two doses of papaverine regarding Pd response and IMR values - 11 ± 4.5 U with 5 mg and 10.6 ± 3 U with 10 mg (p=0.612). The evolution of IMR over time was also similar with the two doses, with significant differences from resting values disappearing after five minutes of intracoronary papaverine administration. IMR increased with disrupted microcirculation in all animals (41 ± 16 U, p=0.001).
CONCLUSIONS: IMR provides invasive and real-time assessment of coronary microcirculation. Disruption of the microvascular bed is associated with a significant increase in IMR. A 5-mg dose of intracoronary papaverine is as effective as a 10-mg dose in inducing maximal hyperemia. After five minutes of papaverine administration there is no significant difference from resting hemodynamic status.
Copyright © 2013 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Animal model; Coronary microcirculation; Index of microcirculation resistance; Microcirculação coronária; Modelo animal; Índice de resistência da microcirculação

Mesh:

Substances:

Year:  2014        PMID: 24793616     DOI: 10.1016/j.repc.2013.09.007

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  4 in total

1.  Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial.

Authors:  Zhanlu Li; Yi Luan; Min Wang; Ya Li; Xiaohua Shen; Guosheng Fu; Wenbin Zhang
Journal:  Trials       Date:  2021-03-08       Impact factor: 2.279

2.  Intracoronary Delivery of Human Mesenchymal/Stromal Stem Cells: Insights from Coronary Microcirculation Invasive Assessment in a Swine Model.

Authors:  António Fiarresga; Márcia F Mata; Sandra Cavaco-Gonçalves; Mafalda Selas; Irina N Simões; Eunice Oliveira; Belmira Carrapiço; Nuno Cardim; Joaquim M S Cabral; Rui Cruz Ferreira; Cláudia L da Silva
Journal:  PLoS One       Date:  2015-10-19       Impact factor: 3.240

3.  Microvascular dysfunction determines infarct characteristics in patients with reperfused ST-segment elevation myocardial infarction: The MICROcirculation in Acute Myocardial Infarction (MICRO-AMI) study.

Authors:  Elisa McAlindon; Maria Pufulete; Jessica Harris; Chris Lawton; Tom Johnson; Julian Strange; Andreas Baumbach; Chiara Bucciarelli-Ducci
Journal:  PLoS One       Date:  2018-11-13       Impact factor: 3.240

4.  Comparative Significance of Invasive Measures of Microvascular Injury in Acute Myocardial Infarction.

Authors:  Annette M Maznyczka; Keith G Oldroyd; John P Greenwood; Peter J McCartney; James Cotton; Mitchell Lindsay; Margaret McEntegart; J Paul Rocchiccioli; Richard Good; Keith Robertson; Hany Eteiba; Stuart Watkins; Aadil Shaukat; Colin J Petrie; Aengus Murphy; Mark C Petrie; Colin Berry
Journal:  Circ Cardiovasc Interv       Date:  2020-05-15       Impact factor: 6.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.